MX2023001410A - Composicion farmaceutica de corticosteroides intraarticulares para el control del dolor. - Google Patents

Composicion farmaceutica de corticosteroides intraarticulares para el control del dolor.

Info

Publication number
MX2023001410A
MX2023001410A MX2023001410A MX2023001410A MX2023001410A MX 2023001410 A MX2023001410 A MX 2023001410A MX 2023001410 A MX2023001410 A MX 2023001410A MX 2023001410 A MX2023001410 A MX 2023001410A MX 2023001410 A MX2023001410 A MX 2023001410A
Authority
MX
Mexico
Prior art keywords
intra
pharmaceutical composition
articular corticosteroid
pain control
corticosteroid
Prior art date
Application number
MX2023001410A
Other languages
English (en)
Spanish (es)
Inventor
Sheue- Fang SHIH
Carl Oscar Brown
Original Assignee
Tlc Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tlc Biopharmaceuticals Inc filed Critical Tlc Biopharmaceuticals Inc
Publication of MX2023001410A publication Critical patent/MX2023001410A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MX2023001410A 2020-08-05 2021-08-05 Composicion farmaceutica de corticosteroides intraarticulares para el control del dolor. MX2023001410A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063061395P 2020-08-05 2020-08-05
PCT/US2021/044619 WO2022031898A1 (en) 2020-08-05 2021-08-05 Pharmaceutical composition of intra-articular corticosteroid for pain control

Publications (1)

Publication Number Publication Date
MX2023001410A true MX2023001410A (es) 2023-03-06

Family

ID=77519828

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023001410A MX2023001410A (es) 2020-08-05 2021-08-05 Composicion farmaceutica de corticosteroides intraarticulares para el control del dolor.

Country Status (14)

Country Link
US (1) US12514820B2 (enExample)
EP (1) EP4192426A1 (enExample)
JP (1) JP2023537474A (enExample)
KR (1) KR20230048066A (enExample)
CN (1) CN116348093A (enExample)
AU (1) AU2021320774A1 (enExample)
BR (1) BR112023001926A2 (enExample)
CA (1) CA3187955A1 (enExample)
CL (1) CL2023000315A1 (enExample)
IL (1) IL300354A (enExample)
MX (1) MX2023001410A (enExample)
TW (1) TW202220668A (enExample)
WO (1) WO2022031898A1 (enExample)
ZA (1) ZA202301377B (enExample)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8956600B2 (en) * 2009-08-10 2015-02-17 Taiwan Liposome Co. Ltd. Ophthalmic drug delivery system containing phospholipid and cholesterol
BR112015000174A2 (pt) * 2012-07-05 2017-06-27 Taiwan Liposome Co Ltd método para o tratamento da artrite
EP4389218A3 (en) * 2017-03-14 2024-10-16 Seikagaku Corporation Composition for treating joint disease and kit containing same
EP3820479B1 (en) * 2018-07-09 2026-03-11 Taiwan Liposome Co., Ltd. Methods to reduce complications of intra-articular steroid
IL281513B1 (en) 2018-09-16 2026-07-01 Tlc Biopharmaceuticals Inc Preparations for the treatment of joint pain

Also Published As

Publication number Publication date
BR112023001926A2 (pt) 2023-03-07
AU2021320774A1 (en) 2023-03-09
EP4192426A1 (en) 2023-06-14
US12514820B2 (en) 2026-01-06
ZA202301377B (en) 2026-05-27
CA3187955A1 (en) 2022-02-10
TW202220668A (zh) 2022-06-01
CL2023000315A1 (es) 2023-09-22
KR20230048066A (ko) 2023-04-10
CN116348093A (zh) 2023-06-27
US20230285293A1 (en) 2023-09-14
JP2023537474A (ja) 2023-09-01
IL300354A (en) 2023-04-01
WO2022031898A1 (en) 2022-02-10

Similar Documents

Publication Publication Date Title
MX2022005994A (es) Uso del inhibidor de fak en la preparacion de un farmaco para el tratamiento contra tumores con mutacion nras.
ZA202202361B (en) Treatment of hidradenitis suppurativa using jak inhibitors
PH12021551792A1 (en) Bi-ligand drug conjugate and use thereof
MY199903A (en) Combination therapy with controlled-release cnp agonists
PH12012501741A1 (en) Treatment of lupus arthritis using laquinimod
MX2017006938A (es) Terapia de combinacion para el tratamiento de cancer.
ZA202006072B (en) Ret inhibitor for use in treating cancer having a ret alteration
MX2024011142A (es) Tratamiento de neurofibromas cutaneos con mirdametinib.
MX2020010034A (es) Metodo de tratamiento de enfermedad fibrotica.
BR112022025920A2 (pt) Tratamento de artrite reumatoide
BR112022024999A2 (pt) Inibidor tlr7 em combinação com prednisolona ou hidroxicloroquina para o tratamento do lúpus eritematoso cutâneo
HK1255584A1 (zh) 使用阿坎酸及d-环丝胺酸的联合疗法
EP1677806A4 (en) METHOD FOR THE TREATMENT OF ACUTE AND HYALURONIC ACIDIFICATION CAUSED BY EXCESSIVE INJURY AND STUPIDATION
ZA202100604B (en) Methods to reduce complications of intra-articular steroid
ZA202101688B (en) Pharmaceutical compositions suitable for articular delivery and use thereof in treatment of joint pain
MX2018005876A (es) Regimen de dosificacion de plasminogeno para la cicatrizacion de heridas.
MX2021002590A (es) Metodos de uso de un compuesto de fenoxipropilamina para tratar el dolor.
WO2021161319A8 (en) Combination therapy for treating amyotrophic lateral using pridopidine and another active agent
BR112021024835A2 (pt) Tratamento para sinuclenopatias
BR112022005765A2 (pt) Tratamento contra afecções espondiloartríticas e psoriáticas com upadacitinib
AR101227A1 (es) Combinaciones de un derivado de n-tiazolil-4-fenoxibencenosulfonamida y un agente farmacéuticamente activo seleccionado a partir de gabapentina y pregabalina para tratar dolor
CL2023000315A1 (es) Composición farmacéutica de corticosteroide intraarticular para el control del dolor
PH12022553441A1 (en) Compositions and methods for treating obsessive-compulsive disorder
MX2022016183A (es) Formulaciones topicas de (1s)-1-fenil-2-piridin-2-iletanamina.
MX2024015758A (es) Metodos para el tratamiento del glioblastoma con profarmacos de riluzol